Table 2.
Outcome variable | Follow-up | Intervention group | Control group | P-value |
---|---|---|---|---|
Mean (95% CI) | Mean (95% CI) | |||
ROM* | Baseline | |||
2 weeks | ||||
6 weeks | ||||
12 weeks | 95 (83–108) | 108 (94–123) | 0.180 | |
SIRAS | Baseline | |||
2 weeks | 12.5 (11.8–13.3) | 13.3 (12.6–14.0) | 0.155 | |
6 weeks | 11.8 (11.0–12.8) | 12.8 (12.0–13.7) | 0.123 | |
12 weeks | ||||
SR adherence for exercise frequency | Baseline | |||
2 weeks | 94.3 (90.7–98.0) | 94.6 (90.8–98.3) | 0.933 | |
6 weeks | 93.2 (86.9–99.5) | 82.9 (76.9–88.8) | 0.020 | |
12 weeks | ||||
SR adherence for exercise duration | Baseline | |||
2 weeks | 94.9 (90.6–99.3) | 93.3 ± 16 (88.9–97.6) | 0.586 | |
6 weeks | 93.8 (89.1–98.5) | 92.6 (88.2–97.0) | 0.721 | |
12 weeks | ||||
SR adherence for exercise quality | Baseline | |||
2 weeks | 86.7 (83.3–90.1) | 87.1 (83.8–90.5) | 0.866 | |
6 weeks | 87.6 (83.4–91.9) | 82.5 (78.4–86.7) | 0.092 | |
12 weeks | ||||
AISEQ | Baseline | 91.5 (88.8–94.2) | 90.5 (87.6–93.7) | 0.994 |
2 weeks | 92.8 (90.7–94.9) | 92.9 (90.2–95.6) | 0.614 | |
6 weeks | 91.5 (89.3–93.8) | 90.4 (87.4–93.5) | 0.600 | |
12 weeks |
ROM: range of motion in the proximal interphalangeal and distal interphalangeal joint; SR: self-reported; SIRAS: Sport Injury Rehabilitation Adherence Scale; AISEQ: Athletic Injury Self-Efficacy Questionnaire. Significant difference between the groups is in bold.
ROM outcomes assessed only at 12 weeks.